Gallegos H, Rojas PA, Sepúlveda F, et al. - Researchers aimed at determining if BCG instillations is associated with the incidence and mortality of COVID-19. They included a total of 175 NMIBC patients in instillations with BCG (induction or maintenance) during 2019/2020, establishing a COVID-19 group (with a diagnosis according to the national registry) and a control group (NO-COVID). Findings revealed a lower case-fatality rate for patients with NMIBC submitted to instillations with BCG relative to the national registry of patients between 70 and 79 years (2.3% vs 14%, respectively). Mortality due to COVID-19 could be lessened with intravesical BCG, hence, they recommend not to suspend instillation schemes in a pandemic.